4.6 Article

Transcriptome Analysis of Natural Killer Cells in Response to Newcastle Disease Virus Infected Hepatocellular Carcinoma Cells

Related references

Note: Only part of the references are listed.
Article Oncology

Association between posttreatment α-fetoprotein reduction and outcomes in real-world US patients with advanced hepatocellular carcinoma

Ghassan K. Abou-Alfa et al.

Summary: A reduction in posttreatment AFP levels of >= 20% is associated with better overall survival and progression-free survival in patients with advanced hepatocellular carcinoma, especially in those with a history of risk factors or higher baseline AFP levels.

CANCER (2023)

Article Veterinary Sciences

Evaluation of the in vitro and in vivo effect of liposomal doxorubicin along with oncolytic Newcastle disease virus on 4T1 cell line: Animal preclinical research

Pooya Faranoush et al.

Summary: This study conducted biochemical and molecular investigations with variable doses of NDV and liposomal doxorubicin on mouse triple-negative mammary carcinoma cell line 4T1 and BALB/c models tumors for the first time. The results showed increased expression of P21, P27, and P53 genes, and decreased expression of CD34, integrin Alpha 5, VEGF, and VEGF-R genes in NDV-treated animal tumors. NDV also increased ROS production, induced apoptosis, reduced tumor size, and significantly improved prognosis in treated mouse models with no adverse effects on normal tissues.

VETERINARY MEDICINE AND SCIENCE (2023)

Review Medicine, General & Internal

Advances in the Study of Antitumour Immunotherapy for Newcastle Disease Virus

Qiuxing Meng et al.

Summary: NDV plays an important role in cancer therapy by activating the immune system and promoting immune cells' anti-tumor response. Additionally, combining with immune checkpoint inhibitors can enhance the anti-tumor effects and improve patient outcomes.

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2021)

Article Multidisciplinary Sciences

Genome-wide CRISPR-Cas9 screen identified KLF11 as a druggable suppressor for sarcoma cancer stem cells

Yicun Wang et al.

Summary: The study identified KLF11 as a negative regulator in sarcoma cancer stem cells, forming a negative feedback loop with YAP/TEAD. Epigenetic silencing of KLF11 in CSCs leads to sustained YAP activation, which is associated with poor prognosis and chemotherapy response in sarcoma patients. Pharmacological activation of KLF11 effectively restored chemotherapy response.

SCIENCE ADVANCES (2021)

Article Oncology

Direct RIG-I activation in human NK cells induces TRAIL-dependent cytotoxicity toward autologous melanoma cells

Juliane Dassler-Plenker et al.

INTERNATIONAL JOURNAL OF CANCER (2019)

Review Cell Biology

Mechanisms of natural killer cell-mediated cellular cytotoxicity

Isabel Prager et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2019)

Article Biotechnology & Applied Microbiology

Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype

Daehwan Kim et al.

NATURE BIOTECHNOLOGY (2019)

Article Multidisciplinary Sciences

Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma

Otilia Menyhart et al.

ROYAL SOCIETY OPEN SCIENCE (2018)

Article Biochemical Research Methods

GOplot: an R package for visually combining expression data with functional analysis

Wencke Walter et al.

BIOINFORMATICS (2015)

Article Immunology

IL-27 stimulates human NK-cell effector functions and primes NK cells for IL-18 responsiveness

Andrea Ziblat et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2015)

Article Veterinary Sciences

Proteomic analysis of chicken peripheral blood mononuclear cells after infection by Newcastle disease virus

Xiaoyu Deng et al.

JOURNAL OF VETERINARY SCIENCE (2014)

Article Biotechnology & Applied Microbiology

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

Michael I. Love et al.

GENOME BIOLOGY (2014)

Article Anatomy & Morphology

TRAIL is Involved in the Tumoricidal Activity of Mouse Natural Killer Cells Stimulated by Newcastle Disease Virus in Vitro

De-Zhi Song et al.

ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2013)

Article Biochemical Research Methods

A systematic comparison of the MetaCyc and KEGG pathway databases

Tomer Altman et al.

BMC BIOINFORMATICS (2013)

Review Microbiology

Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions

Dmitriy Zamarin et al.

FUTURE MICROBIOLOGY (2012)

Article Immunology

Cell-Type-Specific Innate Immune Response to Oncolytic Newcastle Disease Virus

Moanaro Biswas et al.

VIRAL IMMUNOLOGY (2012)

Article Biochemical Research Methods

RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome

Bo Li et al.

BMC BIOINFORMATICS (2011)

Article Otorhinolaryngology

THERAPEUTIC EFFECTS OF A FUSOGENIC NEWCASTLE DISEASE VIRUS IN TREATING HEAD AND NECK CANCER

Pingdong Li et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2011)

Article Immunology

Rap1b facilitates NK cell functions via IQGAP1-mediated signalosomes

Aradhana Awasthi et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2010)

Article Virology

Type I Interferon-Sensitive Recombinant Newcastle Disease Virus for Oncolytic Virotherapy

Subbiah Elankumaran et al.

JOURNAL OF VIROLOGY (2010)

Article Biotechnology & Applied Microbiology

Ultrafast and memory-efficient alignment of short DNA sequences to the human genome

Ben Langmead et al.

GENOME BIOLOGY (2009)

Review Oncology

Overview of cell death signaling pathways

ZY Jin et al.

CANCER BIOLOGY & THERAPY (2005)

Article Immunology

Clinical and immunological effects of Newcastle disease virus vaccine on bovine papillomatosis

S Avki et al.

VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2004)

Article Biochemistry & Molecular Biology

The Gene Ontology (GO) database and informatics resource

MA Harris et al.

NUCLEIC ACIDS RESEARCH (2004)

Review Veterinary Sciences

Newcastle disease virus: macromolecules and opportunities

K Yusoff et al.

AVIAN PATHOLOGY (2001)